Issue areas declared on the filings, ranked by how many filings name each one.
Health Issues
HCR · 45 clients
891 filings
$38.6M on those filings
Medicare/Medicaid
MMM · 30 clients
643 filings
$29.9M on those filings
Taxation/Internal Revenue Code
Who does the lobbying
Every lobbyist named on this registrant's filings.
Darren WillcoxCovered position: Asst. for Policy, Speaker Dennis Hastert; Admin. Asst., Legislative Director, Legislative Asst., Cong. Porter Goss; House Rules Comm. Assoc., Subcommittee Staff Director1,227 filings49 clients · through 2026
Covered positions · 1 of 1 lobbyists named on these filings disclosed a prior government post. A covered official position is the LD-2 field a lobbyist uses to report having held one; the text is reproduced exactly as filed.
Foreign interests disclosed
Every foreign entity named on this registrant's filings.
Sanofi Sa
France
2 filings
through 2017
Actelion Pharmaceuticals Ltd
Switzerland
2 filings
through 2015
Ezbon International Limited
The filings
The 20 most recent of 1,161 filings. Every figure above is built from these records.
This record groups every filed spelling of the registrant's name into one entity, so punctuation variants of the same firm read as one. The grouping is the registrant's normalized name — firms that file under genuinely different names appear separately. Handle: w-strategies-llc.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
Reading this · An LD-2 reports either a fee the registrant charged or expenses it spent, never both on one filing, so the two lists above are different quantities and are ranked separately rather than against each other. The expenses basis is what an organization lobbying on its own behalf files — usually for itself, sometimes for an affiliate under a different name — so a name on the second list is the client the filing names, not necessarily a claim that the registrant lobbied for someone else's account. Across every relationship on file — not just those shown — this registrant reported $49.4M in fees and $0 in expenses.
TAX · 19 clients
167 filings
$6.9M on those filings
Budget/Appropriations
BUD · 15 clients
65 filings
$2.9M on those filings
Copyright/Patent/Trademark
CPT · 14 clients
63 filings
$2.6M on those filings
Medical/Disease Research/Clinical Labs
MED · 2 clients
54 filings
$1.1M on those filings
Trade (domestic/foreign)
TRD · 12 clients
45 filings
$2.1M on those filings
Pharmacy
PHA · 6 clients
31 filings
$1.3M on those filings
Tobacco
TOB · 1 client
29 filings
$1.5M on those filings
Defense
DEF · 6 clients
16 filings
$790K on those filings
Veterans
VET · 7 clients
12 filings
$540K on those filings
Government Issues
GOV · 1 client
11 filings
$550K on those filings
Note · A filing names one to several issue areas and reports a single dollar figure for the period, so the same money appears beside every issue that filing declares. The dollar column is therefore money on filings that named this issue — it is not a split of the total, and these figures sum above it. Filing counts do not double-count.
Virgin Islands (British)
1 filing
through 2022
Ipsen Pharma Sas
France
1 filing
through 2022
Montrago Trustees Limited
Cyprus
1 filing
through 2022
Otsuka
Japan
1 filing
through 2022
Skorpios Trust
Cyprus
1 filing
through 2022
Glaxosmithkline PLC
United Kingdom
1 filing
through 2019
Ipsen Group
France
1 filing
through 2017
Horizon Pharma PLC
United Kingdom
1 filing
through 2016
Glaxosmithkline, PLC
United Kingdom
1 filing
through 2010
What this discloses · An LD-2 reports foreign entities that hold an interest in, or contribute to, the client — so these are foreign interests behind the organizations this registrant files for, not owners of the registrant itself. Disclosure is a reporting requirement, not an allegation.
